ABP798

null · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABP798, covering 2020-08-18 to 2020-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab [Phase 3]